Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Introduction: Vascular factors increase the risk of Alzheimer's disease (AD). We investigated the associations between such factors, longitudinal AD cerebrospinal fluid biomarkers, and cognition. Methods: 433 cognitively normal participants were classified into four biomarker groups using their baseline amyloid (A+/−) and tau status (T+/−). 184 participants had undergone serial cerebrospinal fluid collection. Frequencies of risk factors and the Framingham Risk Score (FRS) were compared, and we tested the influence of risk factors on change in biomarker concentrations and cognition. Results: The absence of obesity, presence of hypertension, and a high FRS were associated with an increase in tau levels, particularly in A+T+ individuals. Risk factors were not associated with amyloid. Depression was associated with higher cognitive scores, whereas high FRS was associated with lower scores and a faster decline. Discussion: Our results demonstrate that vascular risk factors may enhance neurodegeneration but not amyloid accumulation in preclinical AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“We corrected for multiple comparisons, using the false discovery rate adjustment [28], taking into account the testing of five risk factors and the FRS.”
MethodKok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“This may suggest that tau-related pathology is an important contributor to cognitive impairment [40,41] and could be a potential mediator in the relationship between amyloid, vascular factors, and cognitive decline [42].”
BackgroundSelf-citationInverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246 · cited 1×
“5 mL) into polypropylene tubes before freezing at 280 C [25].”
MethodSelf-citationMidlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Bejanin, A., Schonhaut, D. R., La Joie, R., Kramer, J. H., Baker, S. L., Sosa, N., Ayakta, N., Cantwell, A., Janabi, M., Lauriola, M., et al. (2017) · Brain · doi:10.1093/brain/awx243 · Cited by 778
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739 · cited 1×
“This is compatible with studies showing that AD pathology and vascular disorders, as well as concomitant cerebral vascular pathology, often coexist in late-onset AD [34,35].”
ResultAssociation Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650 · cited 1×
“Although results regarding the relationship between AD biomarkers and vascular risk factors have been mixed, an increasing number of cross-sectional biomarker studies report associations with neuronal injury markers [6,7,10,12], but few found a relationship with amyloid [5,6].”
van Charante, E. P. M., Richard, E., Eurelings, L. S., van Dalen, J.-W., Ligthart, S. A., van Bussel, E. F., Hoevenaar-Blom, M. P., Vermeulen, M., & van Gool, W. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30950-3 · Cited by 611 · cited 1×
“Yet, it is less well known, which risk factors have the strongest impact on AD pathology and cognitive decline, making it difficult to develop targeted prevention strategies [15,16].”
BackgroundPetrovitch, H., White, L. R., Izmirilian, G., Ross, G. W., Havlik, R. J., Markesbery, W., Nelson, J., Davis, D. G., Hardman, J., Foley, D. J., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00106-8 · Cited by 468
10-year trajectories of depressive symptoms and risk of dementia: a population-based study
Mirza, S. S., Wolters, F. J., Swanson, S. A., Koudstaal, P. J., Hofman, A., Tiemeier, H., & Ikram, M. A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00097-3 · Cited by 385 · cited 1×
“Although this finding seems counterintuitive, it is consistent with results from our previous study in individuals with mild cognitive impairment [9] and others have shown that severity and trajectory of the depressive symptoms could temporarily impact cognitive performance in various stages of AD [43].”
ResultThe Neuropathology of Older Persons with and Without Dementia from Community versus Clinic Cohorts
Schneider, J. A., Aggarwal, N. T., Barnes, L., Boyle, P., & Bennett, D. A. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1227 · Cited by 372 · cited 1×
“This is compatible with studies showing that AD pathology and vascular disorders, as well as concomitant cerebral vascular pathology, often coexist in late-onset AD [34,35].”
ResultCerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
Schindler, S. E., Gray, J. D., Gordon, B. A., Xiong, C., Batrla‐Utermann, R., Quan, M., Wahl, S., Benzinger, T. L. S., Holtzman, D. M., Morris, J. C., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.01.013 · Cited by 284
Self-citationRabin, J. S., Schultz, A. P., Hedden, T., Viswanathan, A., Marshall, G. A., Kilpatrick, E., Klein, H., Buckley, R. F., Yang, H.-S., Properzi, M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1123 · Cited by 221
Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred
Pastor, P., Roe, C. M., Villegas, A., Bedoya, G., Chakraverty, S., García, G., Tirado, V., Norton, J., Ríos, S., Martínez, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10636 · Cited by 194
Vascular burden and Alzheimer disease pathologic progression
Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b9d · Cited by 156
Self-citationThe Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment
P. Gelber, R., J. Launer, L., & R. White, L. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322618 · Cited by 149
Antecedent Biomarkers of Alzheimer’s Disease: The Adult Children Study
Coats, M., & Morris, J. C. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281881 · Cited by 44
Self-citation
Cited by
Heger, I. S., Deckers, K., Schram, M. T., Stehouwer, C. D. A., Dagnelie, P. C., van der Kallen, C. J. H., Koster, A., Eussen, S. J. P. M., Jansen, J. F. A., Verhey, F. R. J., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012572 · Cited by 67
“line with the idea that these risk factors affect and accelerate both vascular and neurodegenerative pathology.(48) In line with our study, the Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) Risk Score also has been associated with WMH load.”
BackgroundSelf-citationHypertension and Alzheimer’s disease pathology at autopsy: A systematic review
Abdulrahman, H., van Dalen, J. W., den Brok, M., Latimer, C. S., Larson, E. B., & Richard, E. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12707 · Cited by 63
Impact of cardiovascular hemodynamics on cognitive aging
Moore, E. E., & Jefferson, A. L. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.311909 · Cited by 49
Han, G., Bai, K., Yang, X., Sun, C., Ji, Y., Zhou, J., Zhang, H., & Ding, Y. (2022) · Advanced Science · doi:10.1002/advs.202106072 · Cited by 46
Osset-Malla, M., Martínez-Velasco, A., Sánchez-Benavides, G., Buongiorno, M., de la Sierra, A., Shekari, M., Minguillon, C., Kollmorgen, G., Quijano-Rubio, C., Zetterberg, H., et al. (2025) · The Journal of Prevention of Alzheimer's Disease · doi:10.1016/j.tjpad.2025.100304 · Cited by 8
“…[38], another observed that hypertension was linked to a quicker increase in t-tau and p-tau181 levels over time, but only in individuals who were both A + and T + [13], and recent research noted steeper increases in p-tau181 and t-tau among older adults with uncontrolled hypertension [10].”
Metadata
- Authors
- Bos, I., Vos, S. J. B., Schindler, S. E., Hassenstab, J., Xiong, C., Grant, E., Verhey, F., Morris, J. C., Visser, P. J., & Fagan, A. M.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2019-08
- Volume
- 15
- Issue
- 9
- Pages
- 1149-1159
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2964401163
- Cited by
- 64
- References
- 21
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.